Pain and its Interference with Daily Activities among Patients with Cancer in Vinh Phuc Province and Some Related Factors
Main Article Content
Abstract
Objective: This study was conducted to determine the pain severity, pain interference severity with daily activities, and pain-related factors, pain interference-related factors among patients with cancer in Vinh Phuc province.
Materials and methods: A cross-sectional descriptive study was conducted on 116 patients with cancer aged 18 years and older in Vinh Phuc province from January 2023 to the end of June 2023.
Results: The overall average pain score and pain interference score of cancer patients were 3.64±1.5 and 4.57±1.95. Mild pain at 56.9%, moderate pain at 37.9%, and severe pain at 5.2%. Pain interference was mild 33.6%, moderate 50.9%, severe 13.8%, and no obstacle 1.7%. The factors affecting pain are education (Z=-2.26,p=0.024), disease stage (χ2=11.79,p=0.008), pain medication used (χ2=74.56,p=0.00), and the patient's condition (Z=-4.42,p=0.00). Factors affecting pain interference are education (Z=-2.22,p=0.027), disease stage (χ2=9.88,p=0.02), analgesic used (χ2=15.75,p=0.00), perfomance status (Z =-7.1,p=0.00), cancer type (χ2 = 13.16,p=0.04), and pain of patients (χ2 =17.16,p=0.00).
Conclusions: Pain and its interference with daily activities in moderate and severe patients with cancer account for a relatively high rate. The pain of patients with cancer was related to education, stage of disease, pain medication used, and performance status (ECOG). These factors and cancer type are associated with pain interference. The pain of patients with cancer is related to pain interference.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Duc Ba Nguyen et al. (2009), General Oncology, Vietnam Education Publishing House, Hanoi.
II. Lam Thanh Nguyen et al. (2019), Pain status and quality of life of cancer patients treated at Thai Nguyen Oncology Center from January to June 2019, Thai Nguyen Central Hospital.
III. Ministry of Health (2006), "Decision 3483/QD - BYT dated 19/05/2006 on promulgating National Guidelines on Palliative Care for Patients with Cancer and AIDS”.
IV. Ministry of Health (2022), "Decision No. 183/QD-BYT dated 25/01/2022 on promulgating Guidelines for Palliative Care”.
V. Vu Van Vu et al. (2009 - 2010), " Survey on pain and quality of life of advanced cancer patients at Ho Chi Minh City Oncology Hospital 7/2009 - 7/2010", City Medical Journal Ho Chi Minh. 14(4), p. 811 - 822.
VI F Bray, F et al. (2018), "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA: a cancer journal for clinicians. 68(6), p. 394-424.
VII. WHO. The Global Cancer Observatory. (2020), "Vietnam Globocan " .
VII. Aisyaturridha, A., Naing, L., & Nizar, AJ (2006). Validation of the Malay Brief Pain Inventory questionnaire to measure cancer pain. Journal of pain and symptom management, 31 (1), 13-21.
IX. Beck, SL, & Falkson, G. (2001). Prevalence and management of cancer pain in South Africa. Pain , 94 (1), 75-84.
X. Broemer, L., Hinz, A., Koch, U., & Mehnert-Theuerkauf, A. (2021). Prevalence and severity of pain in cancer patients in Germany. Frontiers in Pain Research , 63.
XI. Cleeland, CS (1984). The impact of pain on the patient with cancer. Cancer, 54 (S2), 2635-2641.
XII. Cleeland, CS and Ryan, KM (1994), "Pain assessment: global use of the Brief Pain Inventory", Annals, Academy of Medicine, Singapore.
XIII. Ger, LP, Ho, ST, Wang, JJ, & Cherng, CH (1998). The prevalence and severity of cancer pain: a study of newly-diagnosed cancer patients in Taiwan. Journal of pain and symptom management, 15 (5), 285-293.
XIV. Kalyadina, SA, Ionova, TI, Ivanova, MO, Uspenskaya, OS, Kishtovich, AV, Mendoza, TR, ... & Wang, XS (2008). Russian Brief Pain Inventory: validation and application in cancer pain. Journal of Pain and Symptom Management, 35 (1), 95-102
XV. Klepstad, P., Loge, JH, Borchgrevink, PC, Mendoza, TR, Cleeland, CS, & Kaasa, S. (2002). The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. Journal of pain and symptom management, 24 (5), 517-525.
XVI. Lee, SH, & Chung, BY (2018). Factors influencing pain intensity in patients with advanced cancer. Journal of the Korea Academia-Industrial Cooperation Society, 19 (1), 506-516.
XVII. Reyes-Gibby, CC, Duc, NB, Yen, NP, Nga, NH, Van Tran, T., Guo, H., ... & Cleeland, C. (2006). Status of cancer pain in Hanoi, Vietnam: A hospital-wide survey in a tertiary cancer treatment center. Journal of pain and symptom management, 31 (5), 431-439.
XVIII. Sung, H., Ferlay, J., Siegel, RL, Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 71 (3), 209-249
XIX. Te Boveldt, N., Vernooij-Dassen, M., Burger, N., Vissers, K., & Engels, Y. (2013). Pain and its interference with daily activities in medical oncology outpatients. Pain Physician, 16 (4), 379.
XX. Tegegn, HG, & Gebreyohannes, EA (2017). Cancer pain management and pain interference with daily functioning among cancer patients in Gondar University Hospital. Pain Research and Management, 2017 .
XXI. Van den Beuken-van Everdingen, MHJ, De Rijke, JM, Kessels, AG, Schouten, HC, Van Kleef, M., & Patijn, J. (2007). Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Annals of oncology, 18 (9), 1437-1449.
XXII. Woo, A., Lechner, B., Fu, T., Wong, CS, Chiu, N., Lam, H., ... & Chow, E. (2015). Cut points for mild, moderate, and severe pain among cancer and non-cancer patients: a literature review. Ann Palliat Med , 4 (4), 176-183.
XXIII. Yun, YH, R Mendoza, T., Heo, DS, Yoo, T., Heo, BY, Park, H., ... & Cleeland, CS (2004). Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology, 66 (6), 439-444.